Antimetastatic effect of salvicine on human breast cancer MDA-MB-435 orthotopic xenograft is closely related to Rho-dependent pathway

被引:22
作者
Lang, JY
Chen, H
Zhou, J
Zhang, YX
Zhang, XW
Li, MH
Lin, LP
Zhang, JS
Waalkes, MP
Ding, J
机构
[1] Chinese Acad Sci, Shanghai Inst Mat Med, Div Antitumor Pharmacol, State Key Lab Drug Res, Shanghai 201203, Peoples R China
[2] Chinese Acad Sci, Shanghai Inst Mat Med, Div Phytochem, Shanghai 201203, Peoples R China
[3] Chinese Acad Sci, Grad Sch, Beijing 100864, Peoples R China
[4] NCI, Comparat Carcinogenesis Lab, NIEHS, Res Triangle Pk, NC USA
关键词
D O I
10.1158/1078-0432.CCR-04-2026
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Salvicine is a novel DNA topoisomerase II inhibitor with potent anticancer activity. In present study, the effect of salvicine against metastasis is evaluated using human breast carcinoma orthotopic metastasis model and its mechanism is further investigated both in animal and cellular levels. Experimental Design: The MDA-MB-435 orthotopic xenograft model was applied to detect the antimetastatic effect of salvicine. Potential target candidates were detected and analyzed by microarray technology. Candidates were verified and explored by reverse transcription-PCR and Western blot. Salvicine activities on stress fiber formation, invasion, and membrane translocation were further investigated by immunofluorescence, invasion, and ultracentrifugal assays. Results: Salvicine significantly reduced the lung metastatic foci of MDA-MB-435 orthotopic xenograft, without affecting primary tumor growth obviously. A comparison of gene expression profiles of primary tumors and lung metastatic focus between salvicine-treated and untreated groups using the CLOTECH Atlas human Cancer 1.2 cDNA microarray revealed that genes involved in tumor metastasis, particularly those closely related to cell adhesion and motility, were obviously down-regulated, including fibronectin, integrin a3, integrin beta 3, integrin beta 5, FAK, paxillin, and RhoC. Furthermore, salvicine significantly down-regulated RhoC at both mRNA and protein levels, greatly inhibited stress fiber formation and invasiveness of MDA-MB-435 cells, and markedly blocked translocation of both RhoA and RhoC from cytosol to membrane. Conclusion: The unique antimetastatic action of salvicine, particularly its specific modulation of cell motility in vivo and in vitro, is closely related to Rho-dependent signaling pathway.
引用
收藏
页码:3455 / 3464
页数:10
相关论文
共 52 条
[1]   Formation of actin stress fibers and focal adhesions enhanced by Rho-kinase [J].
Amano, M ;
Chihara, K ;
Kimura, K ;
Fukata, Y ;
Nakamura, N ;
Matsuura, Y ;
Kaibuchi, K .
SCIENCE, 1997, 275 (5304) :1308-1311
[2]   Bacterial toxins that modify the actin cytoskeleton [J].
Barbieri, JT ;
Riese, MJ ;
Aktories, K .
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, 2002, 18 :315-344
[3]   THE GTPASE SUPERFAMILY - A CONSERVED SWITCH FOR DIVERSE CELL FUNCTIONS [J].
BOURNE, HR ;
SANDERS, DA ;
MCCORMICK, F .
NATURE, 1990, 348 (6297) :125-132
[4]   Rho family GTPases regulate mammary epithelium cell growth and metastasis through distinguishable pathways [J].
Bouzahzah, B ;
Albanese, C ;
Ahmed, F ;
Pixley, F ;
Lisanti, MP ;
Segall, JD ;
Condeelis, J ;
Joyce, D ;
Minden, A ;
Der, CJ ;
Chan, A ;
Symons, M ;
Pestell, RG .
MOLECULAR MEDICINE, 2001, 7 (12) :816-830
[5]   Genomic analysis of metastasis reveals an essential role for RhoC [J].
Clark, EA ;
Golub, TR ;
Lander, ES ;
Hynes, RO .
NATURE, 2000, 406 (6795) :532-535
[6]   Integrin-mediated signals regulated by members of the Rho family of GTPases [J].
Clark, EA ;
King, WG ;
Brugge, JS ;
Symons, M ;
Hynes, RO .
JOURNAL OF CELL BIOLOGY, 1998, 142 (02) :573-586
[7]  
Collisson EA, 2003, MOL CANCER THER, V2, P941
[8]  
Fritz G, 1999, INT J CANCER, V81, P682, DOI 10.1002/(SICI)1097-0215(19990531)81:5<682::AID-IJC2>3.0.CO
[9]  
2-B
[10]   Different regions of Rho determine Rho-selective binding of different classes of Rho target molecules [J].
Fujisawa, K ;
Madaule, P ;
Ishizaki, T ;
Watanabe, G ;
Bito, H ;
Saito, Y ;
Hall, A ;
Narumiya, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (30) :18943-18949